Tag: Insulin
ADA: Insulin Delivery Systems Compared in Type 1 Diabetes
Open-source automated insulin delivery compared to sensor augmented pump therapy in adults and children with T1D
Effects of Intranasal Insulin on Cognition, Mobility Studied in Elderly
Evidence from phase 2 trial suggests positive effects on cognition and gait in elderly patients with type 2 diabetes
House Passes Bill To Limit Insulin Costs to $35 a Month
Bill now has to pass the Senate with at least 10 Republican votes
Adding Tirzepatide to Insulin Glargine Ups Glycemic Control in T2DM
For adults with type 2 diabetes and inadequate glycemic control, glycemic control improved with addition of tirzepatide versus placebo
High Endogenous Melatonin Impairs Glucose Tolerance
Lower insulin area under the curve and higher glucose area under the curve observed with late dinner timing
Closed-Loop System Improves Glycemic Control in Young Children With T1DM
Percentage of time with glucose level in target range higher during closed-loop period versus sensor-augmented pump therapy period
Insulin Resistance Linked to Risk for Major Depressive Disorder
Three surrogate measures of insulin resistance linked to increased risk for incident major depression
FDA Approves First Biosimilar Insulin Product
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine), provides cost-effective option
Walmart to Offer Low-Priced Insulin
Insulin prices have skyrocketed in recent years, making it unaffordable for some Americans with diabetes
Exacerbations Down in Asthma Patients on GLP-1R Agonists for T2D
Lower exacerbation counts, fewer health care encounters for asthma symptoms seen in asthma patients with T2D initiating GLP-1R agonists
